Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-15-002150
Filing Date
2015-02-09
Accepted
2015-02-09 16:12:22
Documents
1
Period of Report
2015-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd422135.html 3  
1 FORM 3 rrd422135.xml 3 2089
  Complete submission text file 0001181431-15-002150.txt   3470
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 15588723